[Helicobacter pylori-induced thrombocytopenia]

Area of Science:

• Hematology
• Infectious Diseases
• Immunology

Background:

• Immune thrombocytopenic purpura (ITP) is a bleeding disorder often caused by autoimmune processes targeting platelets.
• While many ITP cases are idiopathic, underlying causes are identified in approximately 20% of patients.
• Helicobacter pylori infection has recently emerged as a potential underlying cause of ITP.

Observation:

• Two male patients with ITP experienced significant increases in thrombocyte (platelet) counts following successful H. pylori eradication.
• The first patient was 75 years old and did not receive experimental therapy.
• The second patient was 47 years old and had not undergone immunosuppressive treatment.

Findings:

• Eradication of H. pylori correlated with a substantial rise in platelet levels in both ITP patients.
• This suggests a potential causal link between H. pylori infection and the development or exacerbation of ITP.
• The observed platelet response occurred without immunosuppressive medication.

Implications:

• H. pylori screening and eradication should be considered a standard diagnostic and therapeutic step for thrombocytopenia.
• This non-invasive, inexpensive treatment may help avoid costly and side-effect-laden immunosuppressive therapies for ITP.
• Further research into the pathophysiology linking H. pylori and ITP is warranted, despite the current evidence of correlation.